Metabolic and inflammatory parameters changes in schizophrenic patients during three months of treatment with long acting risperidone

被引：0
|
作者：
Karlovic, D. [1 ]
Solter, V. [1 ]
Potkonjak, J. [1 ]
机构：
[1] Univ Zagreb, Sestre Milosrdnice Univ Hosp, Dept Psychiat, Zagreb, Croatia
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
10.1016/j.eurpsy.2007.01.509
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [21] Effectiveness of long-acting risperidone for patients with treatment refractory schizophrenia
    Kimura, H.
    Kanahara, N.
    Komasu, N.
    Ishige, M.
    Muneoka, K.
    Yoshimura, M.
    Yamanaka, H.
    Suzuki, T.
    Watanabe, H.
    Sekine, Y.
    Iyo, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 53 - 54
  • [22] Long-acting risperidone in the treatment of institutionalized mentally retarded patients
    Kouniakis, P.
    Tsirogianni, E.
    Baltatzi, M.
    Sidiropoulos, N.
    Hatzitolios, A.
    Giouzepas, J.
    Fokas, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S530 - S531
  • [23] Long acting risperidone in treatment of non-compliant bipolar patients
    Cetin, M.
    Basoglu, C.
    Ebrinc, S. U.
    Semiz, B.
    Algul, A.
    Oguz, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S365 - S366
  • [24] Improvements in illness severity and functioning in schizophrenic patients switched to risperidone long-acting injection (RLAI)
    Peuskens, J.
    Povey, M.
    Diels, J.
    Van der Veken, J.
    Jacobs, A.
    VALUE IN HEALTH, 2006, 9 (06) : A320 - A320
  • [25] Long-acting injectable risperidone improves quality of life in schizophrenic patients: a clinical case series
    Castro-Costa, Erico
    de Castro Andrade, Joao Marcos
    Quites, Lucas
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2008, 30 (04) : 402 - 403
  • [26] Variations in prolactin levels and related symptoms in schizophrenic patients treated with long-acting injectable risperidone
    Kalkavoura, C.
    Theodorou, A.
    Theodoropoulou, P.
    Tzebelikos, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S252 - S252
  • [27] Long term benefits of treatment with risperidone long-acting injection in patients with schizophrenia
    Turner, MS
    Urquhart, E
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S399 - S399
  • [28] Changes in Inflammatory and Metabolic Parameters After Periodontal Treatment in Patients With and Without Obesity
    Altay, Umut
    Gurgan, Cem A.
    Agbaht, Kemal
    JOURNAL OF PERIODONTOLOGY, 2013, 84 (01) : 13 - 23
  • [29] Long-term treatment with long-acting risperidone in Korean patients with schizophrenia
    Lee, Moon-Soo
    Ko, Young-Hoon
    Lee, Sang-Hoon
    Seo, Yong-Jin
    Kim, Seung-Hyun
    Joe, Sook-Haeng
    han, Cg-Su Han
    Lee, Jung-Ho
    Jung, In-Kwa
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (06) : 399 - 407
  • [30] EFFECTIVENESS, TOLERABILITY AND COMPLIANCE OF SCHIZOPHRENIC PATIENTS UNDER TREATMENT WITH ORAL ATYPICAL ANTIPSYCHOTICS OR LONG-ACTING INJECTABLE RISPERIDONE IN DAILY ROUTINE
    Schreiner, A.
    Ibach, B.
    Hargarter, L.
    Diekamp, B.
    EUROPEAN PSYCHIATRY, 2010, 25
12345